Amidst increasing global competition in life sciences, initiatives like bio:cap are emerging to consolidate and strengthen regional ecosystems.
A more connected European life sciences ecosystem can accelerate innovation, attract capital, and create a competitive bloc against leaders in other regions.
Europe's fragmented life sciences sector is actively pursuing greater integration for enhanced collaboration and investment opportunities.
- · European life sciences startups
- · Biotech investors
- · European pharmaceutical industry
Increased cross-border investment and partnership within European life sciences.
Reduced brain drain of scientific talent from Europe to other global hubs.
Europe emerges as a stronger competitor in specific therapeutic areas, challenging US and Asian dominance.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at Sifted